TIMI Score (NSTEMI/UA)
Risk stratification for unstable angina and NSTEMI
Calculator
Why use it
Rapid bedside ACS risk stratification. Guides early invasive vs. conservative strategy decisions. Validated in multiple large trials (TACTICS-TIMI 18, PRISM-PLUS). Widely recommended by ACC/AHA guidelines.
About
The TIMI Risk Score for UA/NSTEMI predicts the risk of death, new or recurrent MI, or need for urgent revascularization within 14 days. It uses seven variables scored 0-1 each, producing a simple bedside risk estimate that guides the intensity of anti-ischemic therapy and invasive strategy timing.
When to use
- Patients presenting with unstable angina or NSTEMI
- Decision on timing of invasive strategy (early vs. delayed)
- Risk communication with patients and families
Formula
Pearls & pitfalls
- TIMI is for NSTEMI/UA only — do not use for STEMI (use TIMI STEMI score separately).
- Each 1-point increase correlates with ~5% increase in 14-day event rate.
- Score ≥ 3 generally favors early invasive approach (catheterization within 24-72h).
- Troponin elevation alone (even marginally) scores +1.
- Aspirin use within 7 days reflects refractoriness to aspirin therapy, not just chronic use.
- GRACE score is an alternative with greater discriminatory power but more complex to calculate.
Next steps
Score 0-2: Low risk (~4-8% event rate), consider conservative strategy. Score 3-4: Intermediate risk (~13-20%), early invasive strategy benefits. Score 5-7: High risk (~26-41%), urgent invasive strategy strongly recommended.
Evidence
Derived from TIMI 11B trial (Antman et al., JAMA 2000). Validated in PRISM-PLUS, TACTICS-TIMI 18, and ESSENCE trials. ACC/AHA Class I recommendation for risk stratification in NSTE-ACS.
References
- Antman EM et al. The TIMI risk score for unstable angina/non-ST elevation MI. JAMA. 2000;284(7):835-842. — link